The non-heme iron-dependent metalloenzyme, rat hepatic phenylalanine hydroxylase (EC 1.14.16.1; phenylalanine 4-monooxygenase (PAH)) was overexpressed in Escherichia coli and purified to homogeneity, allowing a detailed comparison of the kinetic, hydrodynamic, and spectroscopic properties of its allosteric states. The homotetrameric recombinant enzyme, which is highly active and contains 0.7-0.8 iron atoms per subunit, is identical to the native enzyme in several properties: K m , 6-methyltetrahydropterin ‫؍‬ 61 M and L-Phe ‫؍‬ 170 M; V max ‫؍‬ 9 s ؊1 (compared to 45 M, 180 M, and 13 s ؊1 for the rat hepatic enzyme). L-Phe and lysolecithin treatment induce the rPAH T 3 rPAH R (where r is recombinant) allosteric transformation necessary for rPAH activity. Characteristic changes in the fluorescence spectra, increased hydrophobicity, a large activation energy barrier, and a 10% volume increase of the tetrameric structure are consistent with a significant reorganization of the protein following allosteric activation. However, optical and EPR spectroscopic data suggest that only minor changes occur in the primary coordination sphere (carboxylate/histidine/water) of the catalytic iron center. Detailed steady state kinetic investigations, using 6-methyltetrahydropterin as cofactor and lysolecithin as activator, indicate rPAH follows a sequential mechanism. A catalytic Arrhenius E act of 14.6 ؎ 0.3 kcal/mol subunit was determined from temperaturedependent stopped-flow kinetics data. rPAH inactivates during L-Phe hydroxylation with a half-life of 4.3 min at 25°C, corresponding to an Arrhenius E act of 10 ؎ 1 kcal/ mol subunit for the inactivation process. Catechol binding (2.4 ؋ 10 6 M ؊1
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) is shown to occur only at catalytically competent iron sites. Ferrous rPAH binds NO, giving rise to an S T ‫؍‬ 3 ⁄2 spin system.
Phenylketonuria (PKU)
1 is a relatively common inborn error of amino acid metabolism caused by the accumulation of neurotoxins derived from L-phenylalanine. A major clinical manifestation of untreated PKU is progressive postnatal brain damage leading to severe mental retardation that is thought to arise from the decreased protection of myelin proteins against proteolytic degradation. This degenerative process may be slowed in newborns only through the immediate and rigorous implementation of a controlled L-Phe diet. The Mendelian inheritance pattern of this degenerative condition indicates there is a single detoxifying enzyme absent in phenylketonurics. Phenylketonuric liver biopsies show severely reduced or absent phenylalanine hydroxylase (EC 1.14.16.1; L-phenylalanine tetrahydropterin:oxygen oxidoreductase (PAH)) activity, which ordinarily regulates blood [L-Phe] and prevents PKU. Worldwide screening efforts have allowed the identification of over 150 PAH mutations that cause PKU (1) . Mammalian PAH is a soluble, homotetrameric protein (molecular mass ϭ 51.7 kDa) whose activity depends upon the presence of a single non-heme iron center per subunit (2) . Rat hepatic PAH is the most extensively studied of the tetrahydrobiopterin (BH 4 )-dependent amino acid hydroxylases (3, 4) , a highly homologous family of enzymes that includes TyrH and TrpH. These brain enzymes perform the rate-limiting steps in the biosynthesis of catecholamine neurotransmitters and serotonin, respectively. All of the pterin-dependent hydroxylases are thought to contain similar active sites, due to the very high conservation of "catalytic domain" residues, as well as their similar substrates, common biopterin cofactor, and shared sensitivity to potentially chelating inhibitors (3, 5, 6) . The highest level of DNA sequence homology among these enzymes, as well as the location of many of the more severe PKU mutations, occurs in PAH exon 7, which may be of particular importance because it is a constituent of the catalytic core.
PAH interacts in a dual fashion with each of its substrates; in addition to their roles in the catalytic cycle, L-Phe is the obligate allosteric activator of PAH, while reduction of resting state ferric PAH to the ferrous state is performed by BH 4 (7, 8) . Formation of reduced, phenylalanine-activated PAH is concurrent with the appearance of a catalytically competent species (3) .
Activation by L-Phe is typical of a catabolic enzyme's feedforward response to substrate (Fig. 1) . The slow conversion of low activity, T state PAH (PAH T ) to R state PAH (PAH R -[L-Phe]) is facilitated by phosphorylation and inhibited by BH 4 (9 -11) . PAH is isolated from liver in a partially phosphorylated state, due to regulation by phosphorylation/dephosphorylation at Ser-16 (12) . The amino acid substrate specificity is diminished following substrate activation or limited proteolysis (ex-posing a catalytic core) but not by phosphorylation. Under these conditions, for example, PAH will hydroxylate tryptophan at the same 5-position as TrpH (13, 14) .
The PAH active site is of additional interest in that it is able to perform the same spectrum of chemical transformations as cytochrome P450 without benefit of a heme prosthetic group (15) (16) (17) . A variety of other transformations of isosteric amino acids is possible, including epoxidation, aliphatic hydroxylation, and the formation of nitrogen and sulfur oxides (15) (16) (17) . In contrast to the microsomal hydroxylases, PAH activity is tightly regulated at the post-translational as well as transcriptional level, and its oxidative chemistry is much more specific.
The molecular genetics of phenylalanine hydroxylase have been of intense interest ever since the human gene was located (18) because of the molecular nature of PKU, the possibility of preparing vectors for gene therapy (19) , and the ability to prepare PKU-mutant proteins in an effort to link genotype and phenotype (20) . Using heterologous expression followed by activity assays of cell lysate, various PKU mutations have been associated with unstable mRNA, unstable/unfolded proteins, or apparently intact proteins that have low activity (21) . In the last case, the specific origin of the molecular defect in the complicated activation and catalytic pathways of PAH cannot be determined until the protein is purified to homogeneity and compared with a thoroughly characterized wild-type PAH. The dissection of this process into discrete, fully characterized steps and structures is essential for determining both the mechanism of catalysis and ultimately the chemical basis of PKU, but it has not yet been possible because of the heterogeneity of the protein. For instance, the observation of PKU due to diminished sensitivity to L-Phe might be due to either a decreased active site or allosteric site L-Phe affinity, or it might result from improper phosphorylation, subunit assembly, allosteric interactions, etc.
We have embarked upon a research program involving detailed spectroscopic and mechanistic characterization of PAH, with special attention to the active site iron's properties. No previous method of preparing PAH from rat liver tissue or a recombinant source is suitable for the purification of the large amounts (Ͼ100 mg) of spectroscopically homogeneous material that we require. PAH isolated from rat liver is a mixture of alleles, having variable levels of phosphate and different types of tightly bound iron (3) . Recombinant PAH expressed in baculovirus is fully phosphorylated and highly active but would be expensive to manufacture on a large scale (22) . Prokaryotic expression has the potential to provide sufficient quantities of enzyme but has not yet been optimized for yield, iron content, and purity or characterized in sufficient detail. To establish a base line from which we can reliably compare different states and forms of the enzyme, we report an efficient, large-scale expression of rat hepatic PAH in Escherichia coli and a comprehensive set of its kinetic and spectroscopic properties.
The large (ϳ34 kcal/mol) (3) Arrhenius activation barrier to the T 3 R conversion suggests that significant structural distortions of the PAH tetramer occur during allosteric activation. It is not known if the alterations are largely protein-centered or are caused by a change in the coordination environment of the essential active site iron. Using a combination of spectroscopic probes of this process, we show that the direct effects activation has on the active site configuration are limited, while prominent changes occur at the tertiary/quaternary levels of protein structure. The steady state properties of the R state active site, across an unprecedentedly broad range of substrate concentrations, indicate sequential binding of L-Phe, 6-MPH 4 , and O 2 prior to catalytic steps. We introduce a novel adduct of reduced PAH and NO, which models the interaction of Fe 2ϩ and O 2 at the active site and can be used as a structural probe of that complex. A model based on metal-centered, biophysical, and kinetic observations of recombinant PAH is presented to explain the reactivity properties of the enzyme in terms of the T 3 R transition.
EXPERIMENTAL PROCEDURES
Materials-The PRPH3 clone containing a full-length cDNA of rat hepatic PAH was a gift of R. G. H. Cotton and H.-H. M. Dahl (23) . The PKKT7(-E) protein expression vector and host strains JM105 and BL21(DE3) were gifts of S. Schultz and T. Steitz (Yale University). Polyclonal sheep anti-PAH antibody was the gift of J. Tipper and S. Kaufman (National Institutes of Health) (24) . Bovine liver catalase, bovine erythrocyte superoxide dismutase, goat anti-sheep IgG/alkaline phosphatase conjugate, L-Phe, MOPS, phosphates, salts, glycerol, and molecular weight markers were obtained from Sigma. Ampicillin, isopropyl-1-thio-␤-D-galactopyranoside, and DTT were obtained from U. S. Biochemical Corp. Phenyl-Sepharose CL-4B was obtained from Pharmacia (Uppsala, Sweden). 6-MPH 4 was synthesized by standard methods (25, 26) and was stored at Ϫ20°C until use. Induced cells and purified recombinant PAH (rPAH) were stored at Ϫ70°C. All DNAmodifying enzymes were obtained from New England Biolabs or U. S. Biochemical Corp. All other reagents and solvents used were of reagent grade.
Construction of Plasmid Vector-Oligonucleotides were synthesized complementary to the 5Ј-and 3Ј-ends of the desired coding regions of PRPH3, with non-annealing tails containing EcoRI and SalI sites, respectively, immediately adjacent to the PAH-derived sequence. These were used as polymerase chain reaction primers with the linearized cDNA clone PRPH3 as template. The amplified product was then cloned into the EcoRI-SalI sites of PKKT7(-E), which contains the 10 RNA transcription start site recognized by T7 RNA polymerase (27) , as well as a Shine-Delgarno sequence at Ϫ9 with respect to the initiator Met codon. The DNA sequence of expression construct in the region encoding rPAH was obtained from both strands by automated DNA sequencing. Standard molecular biological techniques were used for all of the above (28 H, chlorine, bromine, or CH 3 . Also shown is the recycling of the initial 4a-hydroxypterin product back to reduced tetrahydropterin. In reaction 1, a spontaneous dehydration reaction that is accelerated in liver by 4a-carbinolamine dehydratase/DCoH, q-6-MPH 2 is formed. In reaction 2 this unstable oxidized form of the pterin is reduced, either by dihydropteridine reductase/NADPH (in liver and in the Nielsen/Kaufman assay) (92, 95) or by DTT (Shiman assay) (31) . BL21(DE3) cells (29) transformed by the method of Hanahan (30) was used as the source of protein-producing cultures. These were grown to an A 550 ϭ 1 in BMB broth (described below) at 50 g/ml ampicillin and induced with 0.4 mM isopropyl-1-thio-␤-D-galactopyranoside for 6 h at 30°C in a New Brunswick Instruments fermentor before harvesting. The pH was maintained at 7.6 during the course of the growth, as was vigorous aeration. Antifoam A concentrate was added as necessary. Cells were pelleted at 7500 rpm for 10 min at 4°C. Pellets were resuspended in an equal volume of lysis buffer (30 (8 M) , and KI (6 M). Immediately before the introduction of bacterial cultures, all components were mixed from separate sterile stocks. The iron stock was prepared freshly in 5 mM HCl.
Purification of rPAH-A method adapted from that of Shiman et al. (31, 32) was used to isolate rPAH from induced E. coli cultures. Following sonication of the thawed cell suspension, the lysate was spun 20 min at 18,500 rpm. The supernatant was heated to 25°C and maintained at this temperature for a further 10 min to activate PAH. After clarification by centrifugation (20 min at 18,500 rpm), the supernatant was applied to phenyl-Sepharose CL-4B at 4 bed volumes/h as described by Shiman (32) . Subsequent washes were carried out as has been described, but the buffer A with 5% N,N-dimethylformamide and buffer B washes were carried out at 6 bed volumes/h. Elution with buffer C was also performed as described, except that the second phenyl-Sepharose column was omitted, and the eluate was concentrated directly on a bed of pre-equilibrated DE-52 resin (5 mg rPAH/ml column volume). Following the DE-52 wash and 0.3 M KCl bump steps, the pure rPAH was concentrated to Յ1 ml using either a Centriprep 30 device or ultrafiltration on a YM30 membrane (both Amicon). At this point, the enzyme was judged to be Ͼ95% pure, but if further purification was required, up to 20 mg of rPAH was purified by applying it to a Pharmacia Mono Q 5/5 column (at Յ50 mM KCl), from which a linear gradient between 0 and 300 mM KCl was used to elute essentially homogeneous protein. In some situations, up to 50 mg of purified protein was applied to a Superdex 200 26/60 column (Pharmacia) and eluted with 20 mM phosphate buffer at pH 6.0.
Generally the purifications do not include an iron-addition step. When this step was performed, catalase (2,000 units/ml) and superoxide dismutase (10 units/ml) were added to the supernatant between the first spin and the L-Phe activation step. After 1 min at 25°C, the lysate was made 5 mM in DTT and 0.75 mM in Fe(NH 4 ) 4 (SO 4 ) 2 , followed by the second spin and subsequent purification steps.
Assays-PAH activity was determined using the standard assay, in which the formation of tyrosine from 1 mM L-Phe (in the presence of 60 M 6-MPH 4 and 6 mM DTT) is monitored at 275 nm in 0.1 M phosphate with 3000 units/ml catalase (33) . For the determination of kinetic constants, PAH was preincubated at 25°C with either 1 mM L-Phe for 3 min or 0.5 mM lysolecithin for 5 min. Activated enzyme (5 g/ml at a specific activity of 6 units/mg, where 1 unit ϭ 1 mol of Tyr formed min Ϫ1 ) was added as the last ingredient to a complete assay mixture whose initial velocity was determined, either from the slope of the first 30 s or by direct simulation of the data.
Determinations of L-Phe or lysolecithin activation at equilibrium were carried out as described (33) . Briefly, 20 l at the indicated [activator], containing 10 g of enzyme, was preincubated for 5 min at 25°C and then added as the last ingredient to a standard assay mix at 11°C. The lower temperature is necessary to minimize further activation by 1 mM L-Phe. No significant variation in the initial slope was observed over the first 30 s of reaction, which was the interval used for velocity determinations.
For activity assays performed using stopped-flow detection, the reagents are loaded into two syringes; the first syringe contains rPAH (ϮL-Phe) in phosphate buffer, and the second syringe contains pterin, DTT, and L-Phe in a modification of a previously reported procedure (34) . The solutions are preincubated 5 min at 25°C, loaded into syringes, and equilibrated at the desired assay temperature for 10 min before the first of several injections. Stopped-flow assays show a lag in the first few seconds of assay due to the obligate prereduction of rPAH, which could be avoided by the addition of up to 20 equivalents of 6-MPH 4 to the enzyme-containing syringe.
Observation of the q-6-MPH 2 formed by reduction of rPAH was carried out at 334 nm, where the formation of q-6-MPH 2 results in an increased absorbance (at this wavelength, the molar absorptivities of 6-MPH 4 and 6-MPH 2 are equal and lower than that of q-6-MPH 2 ). In these assays, DTT is omitted, and pterin is added as the last ingredient to an otherwise complete assay mix at pH 8.0 exactly as described. Under these conditions, the 4a-carbinolamine form of 6-MPH 2 (4a-hydroxy-6-MPH 2 ) that is the initial product of the catalytic cycle dehydrates slowly to q-6-MPH 2 , and so the initial product can be identified for each reaction (7) .
Analytical Methods-Routine analytical procedures, including SDS-PAGE and Western blotting, were performed as described in standard handbooks (28) . Protein quantitation was carried out using the Bradford method using bovine serum albumin as a standard, according to the manufacturer's instructions (Bio-Rad). These values were confirmed with total amino acid analyses performed by the Keck Biotechnology Center of the Yale Medical School. A prepacked Superdex 200 26/60 column (Pharmacia) was used for preparative as well as analytical gel filtration.
Phosphate Incorporation-In a typical experiment, 0.1 mg of rPAH (2 nmol) is treated with 4 g of cAMP-dependent protein kinase (Sigma, 5 pmol units) in a total volume of 37.5 l containing the following: 13.5 nmol of [␥-
32 P]ATP (3 Ci total), 0.38 nmol of cAMP, 0.38 nmol of magnesium acetate, 0.75 nmol of DTT, 0.75 nmol of NaF, and 0.75 nmol of potassium phosphate at pH 6.8. A control reaction containing 26.7 g of histones (2 nmol total, Sigma Type VI-S/H 6881) was run in parallel at 30°C. Aliquots of 5 l were withdrawn at different times, mixed into an equal volume of 2 ϫ SDS gel dyes, and frozen in liquid N 2 . These samples were heated to 100°C for 5 min before loading a known fraction of the radioactivity onto a 20% acrylamide gel. Under these conditions, free label is well separated from protein in a "dry" blot of the gel. The radioactivity comigrating with each of the proteins was quantitated on a Betagen (Waltham, MA) Betascope 603 Blot Analyzer.
Other Methods-UV/visible spectra and kinetic measurements were obtained on a Perkin-Elmer Lambda 6 spectrophotometer. Stopped-flow work was performed on a Applied Photophysics DX.17MV sequential stopped-flow spectrometer (Leatherhead, United Kingdom). Fluorescence measurements were acquired on a Spex FluoroMax. Atomic absorption was carried out with a Varian SpectrAA-20. EPR spectra were obtained on a homebuilt spectrometer interfaced to a Macintosh IIx computer (35) . Sample temperatures were determined by calibration with a silicon diode thermocouple located immediately below the sample position. EPR samples of PAH ranged from 0.45 to 0.75 mM in iron and contained 50 mM MOPS, pH 7.2 (5°C), with 300 mM KCl. The NO adduct of 6-MPH 4 -reduced PAH (0.15 mM PAH, 100 mM MOPS, pH 7.2 (5°C), 50 mM KCl) was obtained by the sequential addition of sodium dithionite and sodium nitrite under strict anaerobic conditions according to published procedures (36) . Concentrations of the PAH-NO adduct were estimated by double integration of the EPR spectrum and comparison with the integrated EPR spectrum of a known concentration of Fe 2ϩ ⅐EDTA⅐NO prepared by literature methods (37) . Conversions of approximately 85% were routinely obtained. Experimental conditions are described in the figure legends. CD spectra were obtained on an AVIV 62 DS. Dynamic light scattering data were obtained on a DynaPro 801 (Protein Solutions, Inc., Charlottesville, VA). Analytical small-zone gel filtration experiments were performed on a Pharmacia Superdex 200 26/60 column. Globular size standards used for determining the Stokes radius by gel filtration were apoferritin, catalase, alcohol dehydrogenase, bovine serum albumin, and carbonic anhydrase (38) .
Data Analysis-Catechol titration data were least-squares fit to the following expression:
and solved as a function of C for K and ⑀ (where C ϭ concentration of catechol, E a ϭ concentration of enzyme containing active iron, K ϭ catechol⅐rPAH complex dissociation constant, and ⑀ ϭ complex molar extinction coefficient). Steady state kinetics double-reciprocal analysis was done using Mathematica (Wolfram Research) using the sequential mechanism velocity expression:
where v ϭ initial velocity, V ϭ maximum velocity, K x and K i,x are the Michaelis and dissociation constants for species x, respectively. Data were weighted as the square of the velocities (39) . Routine analyses were performed with KaleidaGraph (Abelbeck Software). Analysis of transient kinetics was carried out using the Kinsim/Fitsim software package by C. Frieden and co-workers (40, 41) , rewritten by G. Mudunuri (Texas A & M, College Station) for use on a Silicon Graphics workstation. The kinetic mechanism used in simulations was that employed by Shiman and Gray (33), in which the L-Phe activation and iron site inactivation are treated as sequential first-order processes.
RESULTS
Overexpression and Purification of rPAH-
The plasmid described here is compatible with the T7 RNA polymerase-coupled systems developed by Studier and co-workers (29) for high level protein expression. The DNA sequence from both strands of the region encoding rPAH was obtained and found to match the protein-coding region sequence reported by Dahl and Mercer (23) with the exception of codon 87, which was found to be AGC (Ser) rather than the expected ACG (Thr). Ser is found at this position in the extremely similar mouse PAH (442/452 amino acid identity, 98%), in an area of the protein thought to be of regulatory rather than catalytic importance. PAH activity detected in the crude lysate of induced cultures increases over 6 h, in register with the appearance of a soluble M r ϭ 51,000 protein in SDS-PAGE. The optical density of induced cultures continues to increase slightly, which suggests that PAH induction is not particularly toxic to the cells. Maximum amounts of soluble rPAH were obtained from inductions at 30°C, yielding ϳ90 mg of purified rPAH from a 10-liter fermentor growth (Fig. 2) .
Direct adaptation of the purification scheme of Shiman et al. (32) for the scale described above resulted in rPAH of activity 7 Ϯ 1 units/mg; purification of protein from two combined 10-liter growths is described in Table I . Recombinant PAH is isolated with specific activity and activation behavior essentially identical to that of enzyme from rat liver. The phenyl-Sepharosebased purification procedure requires that rPAH undergo a reversible, L-Phe-induced increase in hydrophobicity. This affords a purification from incorrectly assembled forms of PAH, some of which may have enzyme activity, thereby lowering the apparent recovery.
The expression of the rat hepatic PAH cDNA in E. coli is correlated with the appearance of a M r ϭ 51,000 protein that cross-reacts with a polyclonal antibody to rat hepatic PAH in a Western blot. Only full-length protein is purified by this procedure, despite the observation of small amounts of a crossreactive 47-kDa protein observed in soluble cell lysate (data not shown). The electrophoretic mobility of rPAH is identical to that of the rat "W" allele, from which the cDNA clone was obtained. Under SDS-PAGE conditions, the minor "I" allele (Ile-371 rather than Thr-371) is resolved at a slightly smaller apparent M r (Ϸ49,000). Total amino acid analysis was performed on the recombinant protein, which was found to agree well with the predicted protein sequence. An extinction coefficient for rPAH could be calculated upon this basis: a 1 mg/ml solution at 25°C in 0.12 M phosphate, pH 6.8, gives rise to an absorbance of 1.05 at 280 nm and gives an apparent Bradford reading of 1.05 mg/ml.
The relatively strong induction of rPAH (on the order of 5% total bacterial protein) allowed the deletion of several items from the standard purification, among them the use of Tween 80 and the use of a second, smaller phenyl-Sepharose column. PAH from rat liver is generally purified with an iron addition step, resulting in stoichiometric amounts of iron and improved activity. The conditions used for iron addition, which involve the addition of ferrous iron to oxygenated buffers in the presence of reductant, are associated with the generation of reactive oxygen species that might damage PAH. Inclusion of enzymes known to scavenge reduced, reactive oxygen species improved the specific activity of the protein purified with an iron addition step from 5 to 8 units/mg. 2 Whether this observed increase in specific activity results from the degradation of peroxide or superoxide, or by some other mechanism, is unknown. In general, purifications including an iron addition step did not result in rPAH of higher specific activity despite the observation of more iron per subunit in treated protein. This has also been observed with partially purified rat hepatic enzyme (42) . Omission of this step altogether results in protein containing near stoichiometric levels of iron (0.7 iron/subunit), with specific activity that depends directly on iron content. This implies that there is very little protein containing inactive iron. This fractional specific activity is consistently 10.5 Ϯ 0.5 units/mg per 1 catalytically competent iron atom/subunit.
Demonstration of Stoichiometric Phosphorylation-Using a modification of previous procedures, we found that T state rPAH is a good substrate for cAMP-dependent protein kinase. The reaction is essentially complete after a 30-min exposure to conditions that phosphorylate Ser-16 (hepatic protein numbering). Unlike previous reports concerning rat hepatic PAH phosphate content, rPAH as isolated appears to be unphosphorylated at this critical residue. In comparison to a saturated histone standard, rPAH incorporates 0.97 Ϯ 0.05 phosphate per subunit (average after 30 min), indicating that initially it was completely unphosphorylated. The reason for this discrepancy with a previous overexpression in E. coli, in which 0.1-0.2 phosphate per subunit was determined, is unknown. These investigators quantitated total protein-associated phosphate Table I ). Lanes 5-7 contain 2 g of protein. B, purification of rPAH to homogeneity. Each lane contains 2 g of protein at the indicated stage of purification. Also shown is rPAH purified through the Mono Q step (see "Experimental Procedures"). C, Western blot of 1 g of protein, developed using a polyclonal antibody to PAH. The functionally similar "W" and "L" alleles can be distinguished in the rat hepatic PAH lane, whereas the rPAH shows only the "W" allele, as expected. Size standard positions are indicated. (43) , whereas our assay is specific for the regulatory phosphorylation site.
rPAH Hydrodynamic Properties-Proper assembly of PAH subunits into a tetrameric structure is an essential prerequisite for allosteric activation behavior. Gel filtration experiments performed at relatively high rPAH concentrations (Ͼ0.4 mM subunit) confirm that rPAH adopts a structure that elutes at a position consistent with a tetramer both in the absence (apparent molecular mass for PAH T , 248 kDa) and presence (apparent molecular mass for PAH R , 270 kDa) of the allosteric activator L-Phe. In analogous studies performed with lower concentrations of homogeneous enzyme (Ͻ0.1 mM subunit), a peak corresponding to a dimer of rPAH is observed (apparent molecular mass for PAH T , 120 kDa). The distribution of rPAH oligomeric species systematically shifts from tetramer to dimer as the pH of the phosphate elution buffer is increased (Fig. 3) . While only qualitative information can be obtained from smallzone gel filtration studies (44) , the observation of distinct bands demonstrates that the self-association of dimers is slow on the time scale of the separation. In parallel experiments, the addition of 0.5 M KCl causes a ϳ10% increase in the proportion of dimer at pH 6.8 but leaves the distribution unchanged at pH 8.0. R state rPAH, generated by prior incubation at 25°C with L-Phe and eluted over the column in buffer supplemented with 1 mM L-Phe, shows a greater propensity to remain tetrameric. The addition of 0.5 M KCl to rPAH R (at either pH 6.8 or 8.0) does not perturb the oligomeric distribution. These observations may bear some relationship to the pH dependence of the obligatory activation phenomenon, which is several times faster at higher pH (pH ϭ 9) than at neutrality and possibly even to the quaternary rearrangement underlying the allosteric transition (45) . Using a calibration curve of the known Stokes radii of several gel filtration standards, Stokes radii could be estimated from gel filtration retention times: rPAH T ϭ 55 Å and rPAH R ϭ 57 Å. These values agree well with the reported value of 55 Å determined by gel filtration for partially phosphorylated resting state rat hepatic PAH (46) . While a detailed description of the structural changes induced by the rPAH T to rPAH R conversion and its effect on the catalytic iron site is still under investigation, the observed ϳ10% increase in the volume of rPAH following activation is consistent with the high apparent Arrhenius activation energy for this process of Ϸ35 kcal/mol (3).
These conclusions are supported by data obtained from dynamic light-scattering studies. The relatively narrow dynamic range of this experiment limited studies to 5 mg/ml rPAH (0.1 mM subunits in 0.1 M phosphate buffer). At this concentration, the Stokes radius observed for rPAH T was 51 Ϯ 2 Å. The same values are obtained at pH 6.0, 8.0, and at pH 8.0 with 0.5 M KCl present. Unfortunately, data from rPAH R samples were unreliable, apparently because of aggregation.
Optical Spectroscopic Characterization-As with the optical spectrum of rat hepatic enzyme, both ferric rPAH T and rPAH R show broad absorbances in the near-ultraviolet and visible spectral regions (300 -400 nm; ⑀ 330 ϭ 3,000 M Ϫ1 cm
Ϫ1
) with a trailing absorbance that extends beyond 500 nm (Fig. 4) . 3 These features, which are absent in optical spectra of both the apoprotein and reduced holoenzyme, have been assigned as arising from histidine-to- ). A common stock of rPAH was prepared by purifying 30 mg of rPAH over Superdex 200 at pH 6.0. A conservative cut from the tetramer peak was saved for rechromatography, excluding aggregate, oligomer, and dimer fractions. Each injection was of 200 g of rPAH diluted freshly 38-fold in the elution buffer (ϳ4 M [subunit] at t ϭ 0); all elutions were done on a single day to avoid artifacts due to freeze-thaw cycles. Chart-recorder traces were manually digitized using Mathematica. The data presented have not been corrected for small variations in the amounts of rPAH injected.
rPAH States and Spectroscopycannot at present be eliminated from discussion, the lack of any LMCT transitions characteristic of tyrosinate-to-Fe 3ϩ , cysteinate-to-Fe 3ϩ , or inorganic sulfide-to-Fe 3ϩ charge-transfer transitions in the visible spectrum allows the elimination of these groups as potential ligands to the active site iron. Thus, the optical spectrum of ferric rPAH is consistent with the presence of coordinated histidine as well as oxygen atom donors such as carboxylates and/or water.
The fluorescence spectrum of PAH is dominated by the characteristic emission of three tryptophans, which can be selectively excited at 293 nm (Fig. 5) . The fluorescence emission of activated rPAH is red-shifted relative to resting enzyme, which is also typical of rat hepatic enzyme (52, 53) . In addition, the rPAH R fluorescence is more susceptible than that of rPAH T to quenching by small molecules, whether anionic or neutral. Quenching of the protein fluorescence by acrylamide or by potassium iodide yielded Stern-Volmer plots analogous to those using comparable concentrations of free tryptophan. This is interpreted as an indication that the fluorophore exposed upon activation behaves as if it were a single tryptophan moving closer to bulk solvent (53). These observations are also consistent with the observed increase in hydrophobicity upon activation that is exploited in the purification procedure.
The CD spectra of T (Fe  3ϩ and Fe   2ϩ ) and R (Fe 3ϩ and Fe 2ϩ ) states of rPAH (Fig. 6 ), obtained at 4 M [subunit] from 400 to 195 nm, were found to be quite similar (Table II) . These spectra were analyzed with a standard basis set to estimate a linear combination of four structural elements, assuming a mean helix length of 10 residues (54). There appears to be a slightly increased fraction of helix in the R state samples compared to T state. Overall, significantly greater helical content was predicted than has been reported elsewhere for PAH, while the distribution of random coil predicted is quite small compared to a previous report. We report data to lower wavelengths (195 nm versus 210 nm) critical to the assignment of secondary structure, which might explain the discrepancy with earlier results (55) .
Catechol Binding Studies-Catechol binds tightly to rPAH T and rPAH R containing a catalytically competent iron site, as determined by the appearance of an intense blue-green color arising from a catechol-to-Fe 3ϩ LMCT band centered at 698 and 435 nm (Fig. 4) (56) . As shown in Fig. 7 , the addition of catechol to rPAH that contains both inactive and active iron (specific activity, 6 units/mg; 0.9 iron/subunit) reaches saturation at 0.6 equivalents of catechol per subunit, consistent with a fractional specific activity of 10.5 Ϯ 0.5 units/mg. Catecholactive iron complex formation occurs with ⑀ 698 ϭ 1900 M Ϫ1 cm Ϫ1 and K d ϭ 3.6 ϫ 10 Ϫ7 M, where the concentration refers to enzyme subunits containing active iron rather than total protein. A second higher energy LMCT band is observed at 435 nm
). Enzyme samples at near-stoichiometric levels of iron per subunit that were allowed to inactivate on the
FIG. 4. Spectra of ferric rPAH T/R and iron-depleted (apo) rPAH
T at 25°C. The holoenzyme T/R spectra were obtained in 50 mM MOPS, 0.3 M KCl (pH 7.3) at 25°C. R state enzyme was generated from T state by addition of L-Phe to 1 mM followed by a 5-min incubation at 25°C. The contribution from buffer and for the R state spectra, L-Phe, has been subtracted. The apoprotein sample was prepared by treating 2 mg of rPAH (specific activity, 6.0 units/mg, 0.9 iron/subunit) with 1 mM o-phenanthroline and 1 l of 10% ␤-mercaptoethanol in a total volume of 250 l. The increase at 510 nm due to the formation of [Fe(o-phen) 3 ] 2ϩ was monitored at 25°C for 60 min, by which time Ն94% of the iron had been removed. Small molecules were removed by passage over a column (0.8 ϫ 6.3 cm) of Sephadex G25 (medium grade, Pharmacia) equilibrated in 0.1 M phosphate, 5% glycerol buffer (pH 6.8).
Glycerol is present to stabilize the apoprotein and facilitate gel filtration, but it tends to exaggerate the molar absorptivity of PAH. A control holoenzyme rPAH T sample that was exchanged into the same 5% glycerol buffer shows a ϳ15% more intense absorbance at 280 nm and stronger absorptions above 290 nm. Inset, difference spectrum showing new chromophores formed upon incubation of ferric rPAH T with catechol. 20 equivalents of catechol were added to 1.06 mg of rPAH T (specific activity, 5.3 units/mg, 0.96 iron/subunit) in a final volume of 0.8 ml in 50 mM MOPS, 0.3 M KCl (pH 7.3) at 25°C. Using ⑀ 698 ϭ 1900 M Ϫ1 cm Ϫ1 determined by active site titrations (described in text), 15 M of the catechol-Fe 3ϩ adduct forms (subunit concentration ϭ 25.7 M), indicating that the fraction of "active" iron is 0.58. Uncomplexed catechol does not absorb above 400 nm under these conditions (data not shown), and its contribution has not been subtracted from the spectrum. Catechol stocks were standardized in methanol, using ⑀ 277 ϭ 2700 benchtop to 3 units/mg and 0.2 units/mg show correspondingly less intense absorbances at 698 nm following the addition of excess catechol. Since the catechol adducts of the catalytically competent Fe 3ϩ sites of rPAH T readily form with uncomplicated kinetics, these data suggest that some structural changes in the primary iron coordination sphere or protein tertiary structure during enzyme inactivation have eliminated access to the active iron center. Of further practical interest is the use of the relatively strong catecholate-to-Fe 3ϩ LMCT transition, which appears in an uncluttered region of the optical spectrum, and the apparent selective binding of catechol to catalytically competent iron sites (i.e. not "inactive" iron, see "Discussion") as the basis of an active iron assay for PAH.
The visible spectra of the catechol adducts of ferric rPAH T and rPAH R are similar to a variety of mononuclear iron complexes (56) . Data from model systems of similar coordination geometries containing ligands of varying Lewis basicities and charge indicate that the catecholate LMCT transitions are sensitive to the ligand environment and undergo a bathochromic shift as the net basicity of the ligands is decreased (56) . As more highly charged oxyanionic ligands (carboxylates) interact strongly with the ferric center, the metal center's intrinsic Lewis acidity decreases, destabilizing metal d-orbitals relative to the filled catecholate orbitals thereby inducing a hypsochromic shift in the LMCT spectrum. Decreasing the basicity of the ligands (by exchanging carboxylate oxygen for N donors) would result in weaker metal-ligand interactions and a smaller catecholate-metal energy gap, which would induce a bathochromic shift in the LMCT spectrum. This effect can be quite dramatic with the low and high energy catecholate LMCT bands ranging from 800 and 495 nm (tris-(2-pyridylmethyl)amine) to 550 and 388 nm (N-(4,6-di-tert-butyl-2-hydroxybenzyl)-N-(carboxymethyl)glycine), with energy shifts of approximately 5700 cm Ϫ1 and 5550 cm Ϫ1 , respectively. While these data suggest that catecholate-to-Fe 3ϩ LMCT transitions are sensitive probes of iron coordination environments, we are currently unable to satisfactorily deconvolute the overlapping contributions of ligand environment from factors such as solvent accessibility to active site, protein matrix environment (charge distribution, micro-dielectric constant) near the iron site, and hydrogen bonding networks that are known to induce significant shifts in the energy (1500 -2000 cm Ϫ1 ) of the LMCT bands for simple model complexes.
EPR Studies-The EPR spectrum of high spin ferric rPAH T (Fig. 8B ) in the noncoordinating MOPS buffer (pH ϭ 6.8) is very similar to that reported for ferric rat hepatic PAH, consisting of broad axial features between 600 and 1400 G. 3 The broad EPR signals of resting state rPAH and hepatic PAH samples suggest that the iron domain maintains a distribution of conformations not due to factors known to induce heterogeneity in the rat hepatic enzyme (mixtures of active and inactive iron sites, presence of the T371I allelic variants, and variable levels of phosphorylation). This effect of micro-heterogeneity arising from slight perturbations in the symmetry of the iron coordination environment has also been noted in the EPR spectra of 4-hydroxyphenylpyruvate dioxygenase (57), the substrate complex of protocatechuate-3,4-dioxygenase (58), and transferrin (59, 60) .
The electronic environment of the ferric center of rPAH T is changed by small coordinating molecules such as Tris buffer. The axial EPR spectrum of rPAH in pH 6.8 Tris buffer (Fig. 8A) is significantly altered from the spectrum in MOPS buffer with two new signals appearing at g eff ϭ 6.7 and 5.4, giving the EPR subunits) . Each of the T state samples was prepared by 2 min, 25°C incubation of 24 nmol rPAH with either 48 nmol 6-MPH 4 or the equivalent volume of buffer (12 l) in a total volume of 90 l. Samples were made 0.1 M in KCl, passed over 2 ml P-10 (Bio-Rad) equilibrated in the same buffer, which was then used to elute protein free of pterin. R states were generated from these samples by addition of L-Phe to 1 mM, followed by a 5-min incubation at 25°C to activate the enzyme. All spectra were obtained at 25°C. Pathlength ϭ 0.5 mm, scan rate ϭ 0.5 nm/s, 5 scans averaged per spectrum. Spectra were base-line corrected using the average value of 250 -300 nm as zero.
TABLE II
Secondary structure predictions from circular dichroism spectra Fits were performed on data from 250 to 195 nm, using the algorithm of Chang, et al. (54) to simulate the linear combination of four structural elements (␣-helix, ␤-sheet, ␤-turn, and random coil) for each of the indicated states. Conditions are described in the legend to Fig. 6 . rPAH States and Spectroscopyspectrum previously reported for rat hepatic PAH (34, 59 -61) .
A significant change in the EPR spectrum is observed upon activation of ferric rPAH T by L-Phe (Fig. 8C) . The broad features observed in the rPAH T spectrum are replaced by a new, prominent resonance at g eff ϭ 4.5 whose intensity decreases with decreasing rPAH specific activity, indicating that it is associated with the catalytically competent iron of rPAH. Activation significantly decreases the apparent micro-heterogeneity that is characteristic of the rPAH T EPR spectrum, suggesting a tightening of the distribution of iron environments under these conditions. The electronic environment of the inactive iron at g eff ϭ 4.3 observed in both the rPAH T and rPAH R samples appears to be unaltered by the activation process. These data are equivalent to those observed for the rat hepatic enzyme. (62) . The spectrum resembles that obtained for bovine adrenal TyrH, which copurifies with a tightly bound catecholamine (63) .
Ferrous PAH, which is the catalytically relevant form of the enzyme, is more refractory to spectroscopic study than the resting, ferric state of the enzyme. The modest Fe 3ϩ -derived optical chromophores disappear, and high-spin Fe 2ϩ (S ϭ 1) becomes undetectable with standard EPR techniques, requiring specialized methods (Mössbauer, MCD, EXAFS) (64) . The binding of nitric oxide, however, generates a yellow, EPR-active {FeNO} 7 adduct (S ϭ 3 ⁄2) with rPAH that will allow its use as a sensitive probe of the geometry and electronic properties of the ferrous active site (65, 66) . The EPR spectrum of the nitric oxide complex of ferrous rPAH T formed by exposure of the pterin-reduced enzyme to ascorbate/nitrite under anaerobic conditions is shown in Fig. 9B . This spectrum (g y,x ϭ 4.12, g Ќ ϭ 3.88) is essentially identical to those reported for the NO adducts of isopenicillin N-synthase (g y,x ϭ 4.09, g Ќ ϭ 3.95) (67), the non-heme iron site of photosystem II (g y,x ϭ 4.09, g Ќ ϭ 3.95) (68) 2Ϫ showed Ͼ85% conversion of enzyme bound iron to the NO adduct (data not shown). Furthermore, since the coordination of two NO molecules to the ferrous center is expected to yield an integer spin system having either no EPR spectrum or one significantly different from that shown in Fig. 9B , it is likely that only one iron coordination site is readily available for NO binding.
Obligate Prereduction of rPAH-Reduction of the enzyme, which is correlated with the ultimate reduction of the ferric center, is required for the formation of tyrosine. Physiological reduction is believed to be performed by the cofactor BH 4 . rPAH reduction is accompanied by an increase in fluorescence and a decrease in the optical absorption in the LMCT region (similar to the apo spectrum in Fig. 4 ). Both enzyme reduction 2). Spectrum B is the nitric oxide adduct of {Fe 2ϩ } rPAH, which was prepared in an argon box under anaerobic conditions. 6-MPH 4 -reduced rPAH (3.5 mg; specific activity, 8 units/mg; 0.7 iron/subunit) was diluted into 310 l of degassed 100 mM MOPS, pH 7.3, with 50 mM KCl (three freeze-pumpthaw cycles). Small aliquots of degassed 0.1 M sodium ascorbate and 1 M NaNO 2 were added alternately in three rounds to a final volume of 1.4 ml. This was concentrated by centrifugation to 0.3 ml and loaded into the EPR tube, which was capped with a new septum. Estimation of the E/D for {FeNO} 7 from the indicated crossing points was performed as described (93) . All EPR samples were frozen slowly by suspension over liquid N 2 , since a suitable glassing agent is unavailable for PAH (94) . and catalytic turnover produce q-6MPH 2 when 6-MPH 4 is used as cofactor, and in the case of reduction it is directly produced by the reaction. In contrast, the addition of 45 equivalents of 6-MPH 4 to 0.2 mg/ml oxidized rPAH R in 1 mM L-Phe (18°C, 0.1 M phosphate, pH 8.0) causes a ϳ1-min lag in the full velocity 4 of q-6-MPH 2 formation that is due to the slow nonenzymatic dehydration of 4a-hydroxy-6-MPH 2 . Ferrous rPAH does not utilize the electrons derived from the reductant during the catalytic oxidation of substrate (7). Enzyme Activation by L-Phe and Lysolecithin-Both rat hepatic PAH and rPAH display a requirement for preincubation with L-Phe to form or expose the PAH active site. The response of PAH activity to L-Phe indicates that it is a homotropic allosteric activator with a complex concentration dependence. Half-maximal equilibrium activation at pH 6.8 occurs at 0.11 mM Phe, compared with 0.12 for rat hepatic PAH (33) . These data (not shown) may be replotted to give a Hill coefficient of 2.25, which is in an intermediate range of cooperativity. The Hill coefficient compares well to a previously reported value for rPAH (1.7) and to the various values reported for the rat hepatic enzyme (2.27-2.6) (43). We performed the same experiment on enzyme activated by lysolecithin, and found that the artificial activator gives rise to a similar fold stimulation in velocity with Hill coefficient 1.3 (data not shown). However, the distribution of oligomeric forms of lysolecithin-activated rPAH (as well as rat hepatic PAH) is unknown.
Initial Velocity Studies with L-Phe or Lysolecithin as Activator-Thorough preincubation with the substrate is a necessary condition for obtaining full activity under a given set of substrate concentrations (as well as a linear initial velocity trace). As a result, the range of L-Phe concentrations available for a double-reciprocal study is constrained between 0.4 and 5 mM, although slight substrate inhibition is observed at the highest [L-Phe] when [6-MPH 4 ] Ͻ 0.5 K 6-MPH 4 . Kinetic constants were determined for rPAH over this narrow range (2.8 -28 K m ) from a standard double-reciprocal set of experiments (inset, Fig. 10 ). The parallel appearance of the lines has been attributed to substrate saturation or inhibition rather than to a ping-pong mechanism. Using an expression for a sequential mechanism, one obtains K phe ϭ 0.37 mM (at 60 M 6-MPH 4 ), K 6-MPH 4 ϭ 38 M (at 1 mM L-Phe), and K i,phe ϭ 0.085 mM. The order of substrate addition is not known but is thought to be at least partially random (72) .
To extend the range of the double-reciprocal plot, we used PAH activated with 0.5 mM lysolecithin, a structurally dissimilar, non-substrate activator. This allowed (Fig. 10 ) the determination of initial velocities at constant [rPAH] over a wide range of L-Phe concentrations, limited only by the sensitivity of the assay (useful between 5 and 35 nmol Tyr min Ϫ1 ml Ϫ1 ) (31). The constants determined from this double-reciprocal plot are quite similar to those arising from the L-Phe-activated rPAH data, with the exception of K phe , which is higher in the L-Pheactivated experiment. This provides further support that under standard steady state conditions, either L-Phe or lysolecithin activation results in a "functionally identical" state of the enzyme (33) . A comparison of these values is given in Table III .
Determination of Arrhenius Activation Energies-The temperature dependence of the initial (30 s) velocity of enzyme preincubated with L-Phe corresponds to an activation energy for the catalytic process of 14.5 Ϯ 1 kcal/mol subunit, compared to 12.0 kcal/mol subunit measured for the rat liver enzyme (33, 55) . The use of stopped-flow detection methods for these activity measurements gave the same velocities as standard methods but more reproducible starting times.
The simulation of tyrosine buildup curves from standard (UV/visible spectra and stopped-flow) assay data afforded the simultaneous determination of both the catalytic (k cat ) and inactivation (k inact ) rates (Fig. 11) . The temperature dependence of k cat values from such simulations agreed well with simple linear approximation of tyrosine buildup in the first 30 s (UV/vis, 14.6 Ϯ 0.6 kcal/mol subunit; stopped-flow, 14.6 Ϯ 0.3 kcal/mol subunit). From simulated values of k inact , we determined the kinetic barrier to irreversible inactivation to be 10 Ϯ 1 kcal/mol subunit with a t 1 ⁄2 of 4.3 min at 25,°C.
The direct observation of the complex activation step (k 1 in Fig. 1 ) is more difficult with rPAH than with rat hepatic PAH 4 It must be emphasized that there was no DTT present in this experiment to distinguish it from recent work that casts doubt on the copper requirement of a PAH from Chromobacterium violaceum. In that work, it is shown that a lag in catalysis is due to removal of inhibitory copper from the enzyme by DTT (85) . Identical activities derive from assays of mammalian, iron-dependent enzyme in the presence or absence of DTT, which is often included to recycle oxidized pterin instead of NADPH/dihydropteridine reductase (31). rPAH States and Spectroscopyunder identical assay conditions. Using a stopped-flow assay and 6-MPH 4 as cofactor, we were able to observe a significantly larger fraction of fully activated velocity present in the unpreincubated rPAH compared to authentic PAH. We were unable to find a value for k 1 by direct simulation with values of k cat and k inact , determined in parallel with L-Phe-preincubated enzyme, without resorting to the assumption that a fraction of unpreincubated rPAH is already in an R state (or determining a k cat for rPAH T ). The reason for this discrepancy with PAH from different sources is unknown and is currently under investigation. DISCUSSION We report the overexpression in E. coli and characterization of recombinant PAH, which has kinetic and physical properties very similar to enzyme isolated from rat liver (Table III) . The observation of tyrosine formation is only one of several important functional aspects of this enzyme. Other reports of PAH expression in vitro have appeared, but in neither of these has a complete description of these essential elements of PAH's mechanism been reported (22, 43) . Such data will be required to understand individual mutations that cause PAH dysfunction and thereby PKU. It is not obvious from an examination of the nature or location of the PKU-associated mutations what is nonfunctional in PKU. Their distributed nature suggests that much of the highly conserved sequence of PAH is carefully balanced to achieve tight regulation of L-Phe catabolism and may be quite sensitive to even "conservative" amino acid substitutions. PAH's normal kinetic complexity reflects the requirement for several configurational changes in the enzyme, some of which may be disrupted or disfavored in PKU. The activities of several PKU mutants have been estimated, several with ϳ10% residual activity (21) . While this can be physiologically quite serious, it may only be caused by a difference of a few kcal mol Ϫ1 in one of the activation barriers for allosteric activation, catalysis, or some other essential feature of PAH. To establish a solid linkage of phenotype with genotype, one needs a detailed structural description of PAH and PAH variants.
As isolated from rat liver, the specific activity of PAH varies from batch to batch in a manner that is attributable to the fraction of "active" iron, as distinguished from sites containing "inactive" iron. Inactive iron cannot perform the hydroxylation reaction, and efforts to restore it to an active state have proven unsuccessful (3) . Inactivation of catalytically competent iron sites is particularly rapid during catalysis; the activity of PAH diminishes in a first-order manner (33) with a half-life of 4.3 min at 25°C. In addition to the uneven phosphorylation of PAH, allelic heterogeneity is present in the common strains of laboratory rats (73) . The fact that PAH forms a tetrameric structure amplifies all of these sources of heterogeneity. By heterologous expression of a single allele of rat hepatic PAH, we avoid a number of these problems. There are no known post-translational modifications of PAH (8, 46, 74) other than phosphorylation (which is easily performed by purified protein kinase (75, 76) ), that would require expression of PAH in a eukaryotic cell line. In addition, E. coli does not contain a suitable pteridine cofactor (77) , which prevents induced rPAH from performing hydroxylation, and thereby autoinactivating, prior to purification. This results in our observation that nearly all of the rPAH-associated iron is bound in the "active" configuration. The successful overexpression of this oligomeric, mammalian protein in E. coli is in conflict with assertions to the contrary (22) and in agreement with a similar accomplishment by Kaufman and co-workers (43). 5 Overexpression of active rPAH tetramers in E. coli confirms that correct quaternary assembly occurs. When activated, rPAH can consume L-Phe at the same rate as rat liver PAH. The recombinant enzyme also shows inhibition of PAH activity at low levels of substrate; this sigmoidal response to L-Phe is indicative of allosteric behavior. In vivo, L-Phe levels may depend directly upon PAH allostery, since they are not depleted below a threshold value equal to the steepest part of PAH's in vitro activation response (33) . Allosteric activation occurs in the rPAH protein following incubation with either L-Phe or lysolecithin, the most commonly used activators of the rat hepatic enzyme. Activation is correlated with characteristic structural changes in the rPAH enzyme as well as the expected increase in initial activity. Light scattering and gel filtration experiments performed on rPAH T and rPAH R indicate that there is a significant increase in the tetramer's size upon activation, which is consistent with the Monod, Wyman, and Changeux (MWC) model for an enzyme undergoing cooperative activation (78) . The observed 3.6% increase in the solution radius is typical of allosteric proteins undergoing homotropic activation; E. coli aspartate transcarbamoylase undergoes a 5.4% increase upon binding of N-(phosphonacetyl)-L-aspartate (79) , and yeast phosphofructokinase undergoes a 4.3% increase upon ATP binding (80) . Lysolecithin activation at equilibrium has a small Hill coefficient, which is consistent with this structurally distinct compound activating PAH by a different mechanism than occurs during L-Phe activation. Regardless of the mechanism of activation, PAH L-Phe R and PAH lysolecithin R have essentially identical catalytic properties, including expanded substrate specificity, and are structurally similar, including a characteristic increase in hydrophobicity (3). In simply referring to "activation" or "activated enzyme," the mechanisms by which PAH becomes fully active are commingled with the kinetic characteristics of that state. We prefer the use of the Monod, Wyman, and Changeux nomenclature (T and R) to refer 5 Other investigators have developed analogous systems for human PAH (86), TyrH (87-89), and TrpH (90, 91).
FIG. 11.
Arrhenius activation parameters under standard PAH assay conditions, analyzed by direct simulation using the model described in Fig. 1 . The temperature dependence of the initial velocity of reduced, L-Phe-preincubated enzyme corresponds to an activation energy for the catalytic process of 14.6 Ϯ 0.6 kcal (mol subunit)
Ϫ1 . An identical result was obtained from the stopped-flow assay method (14.6 Ϯ 0.3 kcal mol
Ϫ1
). The enzyme inactivates during L-Phe hydroxylation, with a half-life of 4.3 min at 25°C. This process has an apparent activation energy of 10 Ϯ 1 kcal (mol subunit)
. Standard assay data were obtained with 7 g/ml rPAH (0.14 M subunits) at a specific activity of 8 units/mg. The stopped-flow data that are shown in the figure were obtained with 5 g/ml rPAH (0.1 M subunits) at a specific activity of 6 units/mg. The error bars for the catalytic rate data fall within the symbols.
rPAH States and Spectroscopyto the two particular configurations of PAH that are associated with distinct kinetic characteristics (78), distinguishing formal allosteric activation from generally stimulatory treatments. Some treatments that increase enzyme activity appear to arise from genuine changes in enzyme structure (high pH, phosphorylation, limited proteolysis), but others seem uncorrelated with such changes ("spontaneous activation" (4)).
A comparison of the spectroscopic properties of rPAH T and rPAH R is presented in Tables II and IV . While the observed differences in Stokes radii, fluorescence, and CD spectral data are consistent with an overall protein structural change upon conversion of rPAH T to rPAH R , the fate of the coordination environment about the iron center is less well defined. Although the energies of the LMCT bands in the optical spectra of native rPAH T and rPAH R as well as those of their respective catechol adducts are equivalent, suggesting that the iron primary coordination sphere remains relatively unchanged, the EPR spectra of these states clearly indicate a change in the iron site electronic structure. Owing to the similar affinities of the independent allosteric effector site (110 M, pH 6.8) and the catalytic site (180 M, pH 6.8) for L-Phe, it is expected that both sites will be fully occupied under the experimental conditions generally used for the complete conversion of rPAH T to rPAH R . We are therefore unable to fully assess whether the observed changes in the EPR spectra are a consequence of the effect of substrate in the active site or by changes in the iron coordination environment induced by the structural reorganization accompanying the rPAH T to rPAH R conversion. However, the electronic spectral data are consistent only with the former possibility. A more extensive study of the EPR and Mössbauer spectra of the various states available to rPAH will appear elsewhere. 6 The absence of phosphate in the E. coli-expressed rPAH further confirms that the low, variable levels of phosphate content in liver protein are not required for, nor are they equivalent to, allosteric activation. The half-maximal activation response of unphosphorylated rPAH T occurs at the same concentration as partially phosphorylated (0.2-0.3 phosphate per subunit) PAH. This suggests that the stimulatory effect of phosphorylation is not expressed at low levels of phosphate content. The observation of a K phe identical to that of rat hepatic PAH confirms that phosphorylation affects only the regulatory L-Phe site; it does not perturb the active site L-Phe affinity or any catalytic properties. Only L-Phe and lysolecithin have been shown to cause a cooperative, sigmoidal activation response (at [effector] Ͻ 1 mM), using either BH 4 or 6-MPH 4 . Phosphorylation sensitizes the enzyme to its substrate by lowering the concentration of L-Phe necessary for activation (9) without affecting the sigmoidal shape of the response, causing more effective in vivo catabolism (81) .
Hydroxylation of L-Phe by rPAH requires molecular oxygen, L-Phe, and a pterin cofactor, with maximal activity at one atom of iron per subunit. The remarkable chemistry performed by PAH depends upon the correct positioning of these substrates near the active site iron. This occurs with either 6-MPH 4 or the natural cofactor BH 4 . Variations in the structure or orientation of this side chain (or addition of a 7-substituent), which does not participate directly in the reaction, can lead to "uncoupling" of the hydroxylation of L-Phe from the oxidation of tetrahydropterin (82) . Both pterins are efficiently used as cofactors for rPAH, but the initial time course of a standard assay using BH 4 has a pronounced curvature (data not shown) that makes the assignment of initial velocities difficult. Shiman and co-workers (11) have recently reported similar but less pronounced phenomena in a study of rat hepatic PAH, which they ascribed to BH 4 -dependent relaxation of the activated enzyme (R 3 T) (11) . The inhibitory characteristics of BH 4 are well known, among them prevention of substrate activation (3) and inhibition of phosphorylation (9) . Full phosphorylation of the enzyme may obliterate the BH 4 regulatory site (9) . The observations are consistent with BH 4 acting as a classic negative allosteric effector, i.e. one that preferentially binds to and stabilizes the T state. The determination of an Arrhenius activation energy for rPAH's allosteric activation has been hampered by a kinetic difference in the T 3 R conversion process of rPAH. However, activation by L-Phe at equilibrium causes 12-fold stimulation of the initial velocity, occurs at the same concentrations of applied activator, and yields a similar Hill coefficient.
Prereduction of ferric PAH is required for activity and can be detected as an initial absorbance decrease in a standard assay of oxidized rPAH R performed on a stopped-flow. Reduced PAH R binds both of its substrates and a molecule of O 2 , which is activated for hydroxylation within a complex of pterin, L-Phe, and {Fe 2ϩ } PAH. The mechanism of O 2 activation and the identity of the hydroxylating intermediate are unknown. Pterin does not appear to coordinate directly to the active iron (83) but is generally accepted to be an essential component of the active site. The catechol and NO adducts of the ferric and ferrous forms of the enzyme will be quite useful in assessing the catalytic importance of vacant iron coordination sites, in the presence and absence of the tetrahydropterin coenzyme.
Earlier studies designed to examine the steady state equilibrium kinetic mechanism of PAH were apparently performed prior to the realization that thorough preactivation of PAH is required for maximal enzyme activity. The determination of a sequential mechanism for PAH indicates that all three substrates are ordered at the active site before any product is released. Reliance upon L-Phe activation under steady state conditions severely limits the range of concentrations available for study (72) . The L-Phe activated results alone do not allow the assignment of a sequential or ping-pong mechanism since parallel and intersecting lines are difficult to distinguish over a narrow range of substrate concentrations (84) . Lysolecithin allows the assay of rPAH at low concentrations of [L-Phe] without complications due to the activator role of this substrate. Lysolecithin was maintained at Ն0.5 mM throughout the modified standard assay to ensure stable activation of rPAH. In this way, the double-reciprocal analysis of PAH at 4 ] high enough to observe pterin inhibition were not encountered during either experiment, as both of these studies were limited by the background autooxidation of ] to low levels of this cofactor (Յ3 K app ). Significant substrate inhibition with lysolecithin-activated rPAH (at any ]) below 2 mM L-Phe was not observed, in contrast with a previous report that such inhibition begins above 0.3 mM L-Phe (13) . In summary, we have compared the kinetic requirements of rPAH to rat hepatic PAH in detail and find that the recombinant enzyme recapitulates every catalytic detail. There is stimulation of the rate of hydroxylation following exposure to the same allosteric activators; rPAH has the same requirement for reduced iron and the same affinity for its substrates. The temperature dependence of the catalytic step of rPAH yields a similar kinetic activation energy barrier. In addition, we have measured an Arrhenius activation barrier for the poorly understood kinetic inactivation process of PAH. Overexpressed rPAH is synthesized quickly (in 6 h versus several days for a eukaryotic expression system (22) ) in an environment free of pterin cofactor and general phosphorylating conditions, which results in a homogeneous preparation free of complications due to inactive iron and uneven phosphorylation. By many structural criteria, rPAH is essentially equivalent to rat hepatic PAH.
The availability of this source of rPAH will aid in the resolution of several long-standing issues pertaining to the chemistry and structure of PAH. One of the most important is the nature of the allosteric activation process (T 3 R conversion), which we have shown by UV-visible spectra and CD spectroscopy causes only minor changes in the carboxylate/histidine coordination environment of the active site iron and the overall secondary structure of the protein. There is at least one partially accessible, labile coordination site on the iron (Fe 3ϩ and Fe 2ϩ ) present in T state rPAH, demonstrated by the ready formation of Tris, catechol, and NO adducts. However, rPAH T is able to preclude access to the iron site by its substrates, directing them instead to the allosteric L-Phe site and the pterin reduction site, which are functionally and/or spatially distinct from the rPAH R active site. In support of this, EPR spectra show that both T and R state PAH have mostly rhombic active site environments, but in the latter case increased L-Phe accessibility to the active site causes perturbations due to its binding near the iron. 6 Spectroscopic data are consistent with the immediate iron environment being relatively insensitive to the allosteric state of the enzyme. Characteristic fluorescence shifts, increased hydrophobicity, a large activation energy barrier, and a 10% volume increase are suggestive of a large reconfiguration of the distant protein matrix following allosteric activation. This process can now be more reliably envisioned as resulting from the removal of an inhibitory portion of the protein, exposing a functional active site, rather than as a L-Phe-dependent rearrangement of the iron ligands.
